Northwestern University is using an economics theory to rehab people with lousy health habits. Researchers want participants to just change two unhealthy behaviors to see if the others will tag along. Sort of a buy two, get two free sale based on the Behavioral Economics Theory used by Nobel Prize winner Daniel Kahneman. Couch potatoes also get an arsenal of high-tech tools to help them make the changes.
A blood cell known as a troublemaker for triggering the itch and inflammation in allergy attacks, the mast cell, can also calm down the flare-ups, researchers from Stanford University School of Medicine have found.
As children head back to the classroom, Health Canada is reminding parents of the importance of allergy awareness when packing lunches for their children.
The Canadian Food Inspection Agency (CFIA) is warning people with allergies to walnuts (walnut allergy) not to consume Bella Cucina Death by Chocolate cookies.
A promising new HIV vaccine created at The Wistar Institute has received funding for clinical development aimed at moving the vaccine into human clinical trials as soon as possible.
Two University of Virginia School of Medicine researchers have been awarded grants from the National Institute of Allergy and Infectious Diseases to develop treatments and tests for some rapidly emerging trouble spots in the area of gastrointestinal diseases.
A patient?s expectations about the side effects of chemotherapy usually focus on nausea, hair loss, fatigue and other side effects. Worries about severe allergic reactions to their therapy is usually not a concern.
An investigational drug called ecallantide (also known as DX-88 [Dyax Corp., Cambridge, MA]) significantly relieves attacks of a rare, life-threatening disease called hereditary angioedema, report researchers from Children’s Hospital Boston and 25 other study sites.
A vaccine against anthrax that is more effective and easier to administer than the present vaccine has proved highly effective in tests in mice and guinea pigs, report University of Michigan Medical School scientists in the August issue of Infection and Immunity.
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a UCLA research team a five-year, $9 million contract to fund a multicenter study investigating antibiotic treatments for MRSA, a staph infection seen increasingly in communities across the nation that is resistant to antibiotics most commonly used to treat skin infections.